JHCL

Jones Hill Capital LP Portfolio holdings

AUM $466M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$466M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1 +$74M
2 +$50.6M
3 +$35M
4
NUVL icon
Nuvalent
NUVL
+$30.7M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
1
BioMarin Pharmaceuticals
BMRN
$10.3B
$71.7M 15.36%
+1,268,390
VRTX icon
2
Vertex Pharmaceuticals
VRTX
$114B
$48.5M 10.4%
+108,603
PCVX icon
3
Vaxcyte
PCVX
$7.73B
$37.5M 8.03%
+644,831
NUVL icon
4
Nuvalent
NUVL
$8.25B
$30.8M 6.61%
+300,830
CAPR icon
5
Capricor Therapeutics
CAPR
$1.72B
$27.6M 5.93%
+909,207
TERN
6
DELISTED
Terns Pharmaceuticals
TERN
$27.5M 5.89%
+521,237
BCAX
7
Bicara Therapeutics
BCAX
$1.36B
$25.1M 5.37%
+1,260,136
ANIP icon
8
ANI Pharmaceuticals
ANIP
$1.81B
$24.5M 5.25%
+318,591
RARE icon
9
Ultragenyx Pharmaceutical
RARE
$2.54B
$24.4M 5.23%
+1,165,557
ELVN icon
10
Enliven Therapeutics
ELVN
$2.62B
$23.2M 4.98%
+593,040
AMLX icon
11
Amylyx Pharmaceuticals
AMLX
$1.54B
$22.2M 4.76%
+1,598,794
ARGX icon
12
argenx
ARGX
$51.1B
$19M 4.07%
+25,995
FULC icon
13
Fulcrum Therapeutics
FULC
$474M
$13.6M 2.91%
+1,771,926
VIR icon
14
Vir Biotechnology
VIR
$1.53B
$10.7M 2.3%
+1,198,213
NUVB icon
15
Nuvation Bio
NUVB
$1.64B
$10.2M 2.19%
+2,383,031
ORKA
16
Oruka Therapeutics
ORKA
$3.82B
$6.91M 1.48%
+140,843
CTNM
17
Contineum Therapeutics
CTNM
$531M
$6.7M 1.44%
+513,053
MANE
18
Veradermics Inc
MANE
$4.4B
$6.37M 1.37%
+100,843
TNXP icon
19
Tonix Pharmaceuticals
TNXP
$225M
$6.22M 1.33%
+452,116
GPCR icon
20
Structure Therapeutics
GPCR
$2.83B
$4.85M 1.04%
+100,593
TRDA icon
21
Entrada Therapeutics
TRDA
$265M
$4.72M 1.01%
+374,010
PHVS icon
22
Pharvaris
PHVS
$2.16B
$4.72M 1.01%
+167,014
TRVI icon
23
Trevi Therapeutics
TRVI
$2.14B
$4.42M 0.95%
+370,175
RLMD icon
24
Relmada Therapeutics
RLMD
$778M
$2.39M 0.51%
+342,752
SLN
25
Silence Therapeutics
SLN
$337M
$1.59M 0.34%
+301,604